Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Queensland Health
QuintilesIMS
Federal Trade Commission
Fuji

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,862,772

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,862,772
Title:Compositions and methods
Abstract: The invention relates to a composition comprising an anchor region capable of binding to a plasma cell; and a binding region associated with the anchor region, wherein the binding region binds a specific plasma cell antibody.
Inventor(s): Radbruch; Andreas (Berlin, DE), Hiepe; Falk (Berlin, DE), Taddeo; Adriano (Berlin, DE), Gerl; Velia (Berlin, DE), Hoyer; Bimba F. (Berlin, DE), Chang; Hyun-Dong (Berlin, DE), Theiel; Andreas (Berlin, DE)
Assignee: BEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DRFZ) (Berlin, DE)
Application Number:14/426,650
Patent Claims:see list of patent claims

Details for Patent 9,862,772

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Try a Free Trial BEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DRFZ) (Berlin, DE) 2032-09-07 RX search
Glaxo Grp Ltd ARZERRA ofatumumab INJECTABLE; INJECTION 125326 001 2009-10-26   Try a Free Trial BEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DRFZ) (Berlin, DE) 2032-09-07 RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28   Try a Free Trial BEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DRFZ) (Berlin, DE) 2032-09-07 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKinsey
QuintilesIMS
Boehringer Ingelheim
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.